Diabetologia

Diabetologia is a monthly peer-reviewed journal published by Springer as the official journal of the European Association for the Study of Diabetes, founded in 1965 and devoted to clinical, translational and experimental research on diabetes and metabolism, with a 2025 Journal Impact Factor of 10.4《糖尿病学》（Diabetologia）是（Springer）出版的月刊同行评审期刊，为欧洲糖尿病研究学会（EASD）官方期刊，1965 年创刊，致力于糖尿病与代谢领域的临床、转化与实验研究，2025 年影响因子为 10.4。

Scope

• The journal publishes original clinical, translational and experimental research on all aspects of diabetes and related subjects, provided it has scientific merit and represents an important advance in knowledge该刊发表糖尿病及相关课题的原创临床、转化与实验研究，要求具有科学价值并代表知识的重要进展。
• Its stated goals are to publish the best research and the most lively and informative opinion about diabetes, to serve as a forum for debate about science, clinical care and public health issues, to further the interests of the diabetes research community in Europe and around the world, and to facilitate the translation of scientific advance into clinical benefit for people with diabetes其既定目标包括刊发糖尿病领域最优秀的研究与最有活力的观点，搭建科学、临床护理与公共卫生议题的辩论平台，增进欧洲及全球糖尿病研究界的利益，并促进科学进展向糖尿病患者临床获益的转化。
• Its subject range is summarised as clinical, translational and experimental diabetes and metabolism其学科范围概括为糖尿病的临床、转化与实验研究以及代谢疾病。
• The journal charges no submission fee, no page charge and no charge for colour illustrations, and authors at participating institutions may publish open access at no cost, while other authors can use the Open Choice programme of the publisher该刊不收取投稿费、版面费与彩色插图费，参与机构的作者可免费开放获取发表，其他作者可采用出版方的（Open Choice）方案。
• A rapid triage system redirects out-of-scope manuscripts to a more appropriate journal without delay该刊设有快速分诊系统，可将超出范围的稿件迅速转投更合适的期刊。
• It is abstracted and indexed in the Science Citation Index Expanded, Scopus, MEDLINE, EMBASE, Current Contents, Chemical Abstracts Service and dozens of further databases该刊被（SCIE）、（Scopus）、（MEDLINE）、（EMBASE）、（Current Contents）、（CAS）等数十个数据库收录。
• The publisher reports 8.7 million downloads in 2025 and nearly 1900 open access articles on its platform出版方统计该刊 2025 年下载量达 870 万次，平台上开放获取文章近 1900 篇。

History

• The first issue appeared in August 1965 and opened with a report of the first annual meeting of the European Association for the Study of Diabetes, held at Montecatini Terme in April 1965该刊首期于 1965 年 8 月出版，开篇为 1965 年 4 月在（Montecatini Terme）举行的欧洲糖尿病研究学会首届年会的报告。
• Early volume numbering ran at more than one volume per year, with volume 20 dated January 1981, and the journal settled at one volume per year from volume 30 in 1987早期卷号每年不止一卷，第 20 卷为 1981 年 1 月，自 1987 年第 30 卷起固定为每年一卷。
• Editors-in-chief since 1965 have included Karl Oberdisse, Edwin Gale, Juleen Zierath and Sally Marshall1965 年以来的主编包括（Karl Oberdisse）、（Edwin Gale）、（Juleen Zierath）与（Sally Marshall）。
• Hindrik Mulder, professor of metabolism at Lund University in Sweden, has edited the journal since 2021, with his term running to December 2026 and Patrick Schrauwen announced as incoming editor-in-chief at the 2026 EASD annual meeting瑞典隆德大学代谢教授（Hindrik Mulder）自 2021 年起任主编，任期至 2026 年 12 月，接任者（Patrick Schrauwen）已在 2026 年（EASD）年会上宣布。
• A sister journal, Metabologia, was launched at the EASD annual meeting in 2025 with Jennifer Sargent as editor-in-chief其姊妹刊（Metabologia）于 2025 年（EASD）年会上创刊，主编为（Jennifer Sargent）。
• Its impact factor has stayed close to ten in recent years, recorded as 10.122 for 2021, 10.46 for 2022, 10.2 for 2024 and 10.4 for 2025其影响因子近年稳定在 10 左右，2021 年为 10.122，2022 年为 10.46，2024 年为 10.2，2025 年为 10.4。
• The journal reaches volume 69 in 2026 and is issued monthly, twelve issues a year该刊 2026 年出版至第 69 卷，按月出版、每年 12 期。

Editors

• Hindrik Mulder is the editor, and he also runs a weekly outpatient clinic for diabetes patients at the Department of Endocrinology of Skane University Hospital in Sweden（Hindrik Mulder）任主编，并在瑞典（Skane University Hospital）内分泌科每周出诊糖尿病门诊。
• Anna Krook serves as deputy editor-in-chief and Christian Herder as reviews editor（Anna Krook）任副主编，（Christian Herder）任综述编辑。
• Cheryl Pritlove is the equity, diversity and inclusion lead, and Judy Naylor is the managing editor（Cheryl Pritlove）任公平、多元与包容事务负责人，（Judy Naylor）任管理编辑。
• Twenty-six associate editors guide manuscripts through the peer-review process and make final recommendations to the editor-in-chief26 位副主编负责稿件的同行评审流程，并向主编提出最终推荐意见。
• The associate editors include Tim Curtis, Ketan Dhatariya, Jan Eriksson, Gian Paolo Fadini, Sophia Zoungas and the incoming editor Patrick Schrauwen副主编包括（Tim Curtis）、（Ketan Dhatariya）、（Jan Eriksson）、（Gian Paolo Fadini）、（Sophia Zoungas）与接任主编（Patrick Schrauwen）。
• An advisory board provides advice and guidance in specialist areas of diabetes research另设顾问委员会，在糖尿病研究的各专门领域提供咨询与指导。